ALABISO, Oscar
 Distribuzione geografica
Continente #
EU - Europa 3.422
NA - Nord America 3.170
AS - Asia 1.763
SA - Sud America 157
AF - Africa 32
Continente sconosciuto - Info sul continente non disponibili 8
OC - Oceania 5
Totale 8.557
Nazione #
US - Stati Uniti d'America 3.108
RU - Federazione Russa 762
IE - Irlanda 733
SG - Singapore 620
CN - Cina 476
DE - Germania 456
SE - Svezia 360
UA - Ucraina 298
HK - Hong Kong 270
IT - Italia 246
FR - Francia 199
FI - Finlandia 190
VN - Vietnam 188
BR - Brasile 123
GB - Regno Unito 77
IN - India 57
CA - Canada 40
KR - Corea 28
PL - Polonia 22
IR - Iran 20
AR - Argentina 17
BD - Bangladesh 16
BE - Belgio 15
MX - Messico 14
ID - Indonesia 12
TR - Turchia 12
AT - Austria 10
CZ - Repubblica Ceca 10
LT - Lituania 10
ES - Italia 9
JP - Giappone 9
NL - Olanda 9
ZA - Sudafrica 8
EU - Europa 7
IQ - Iraq 7
PK - Pakistan 7
CO - Colombia 6
EC - Ecuador 6
AE - Emirati Arabi Uniti 5
AU - Australia 5
EG - Egitto 4
ET - Etiopia 4
JO - Giordania 4
KE - Kenya 4
KZ - Kazakistan 4
PH - Filippine 4
UZ - Uzbekistan 4
VE - Venezuela 4
BJ - Benin 3
KG - Kirghizistan 3
TH - Thailandia 3
TN - Tunisia 3
AL - Albania 2
BB - Barbados 2
CH - Svizzera 2
DO - Repubblica Dominicana 2
JM - Giamaica 2
LB - Libano 2
MA - Marocco 2
MD - Moldavia 2
MU - Mauritius 2
MY - Malesia 2
PT - Portogallo 2
SA - Arabia Saudita 2
AM - Armenia 1
BA - Bosnia-Erzegovina 1
BG - Bulgaria 1
BO - Bolivia 1
CY - Cipro 1
DK - Danimarca 1
DZ - Algeria 1
GE - Georgia 1
GR - Grecia 1
IL - Israele 1
LV - Lettonia 1
NP - Nepal 1
PA - Panama 1
PS - Palestinian Territory 1
QA - Qatar 1
RO - Romania 1
RW - Ruanda 1
SI - Slovenia 1
SK - Slovacchia (Repubblica Slovacca) 1
TT - Trinidad e Tobago 1
TW - Taiwan 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 8.557
Città #
Dublin 733
Jacksonville 527
San Jose 333
Dearborn 277
Hong Kong 268
Singapore 205
Ashburn 198
Wilmington 157
Chandler 136
Beijing 125
Moscow 109
San Mateo 93
Lawrence 92
Princeton 92
Ann Arbor 90
Lauterbourg 74
Los Angeles 70
Andover 65
Hanoi 54
Council Bluffs 52
Dallas 49
Bremen 48
Buffalo 48
Ho Chi Minh City 44
Piemonte 42
New York 40
Orem 32
Munich 31
Santa Clara 30
Grafing 29
Seoul 26
Torino 26
São Paulo 23
Houston 19
Brooklyn 18
Redondo Beach 18
Warsaw 18
Boardman 16
Guangzhou 16
Nanjing 16
Brussels 15
Chennai 15
Helsinki 15
Nuremberg 15
Rome 15
Boston 14
Chicago 14
Haiphong 13
Tianjin 13
Dong Ket 12
Hefei 12
Milan 12
Norwalk 12
Stockholm 12
Toronto 11
Woodbridge 11
Da Nang 10
Kunming 10
Manchester 10
Atlanta 9
Brno 9
Frankfurt am Main 9
Tokyo 9
Augusta 8
Denver 8
Montreal 8
Philadelphia 8
Poplar 8
West Jordan 8
Zanjan 8
Hangzhou 7
Leawood 7
London 7
Monmouth Junction 7
Mumbai 7
Shanghai 7
Barnet 6
Düsseldorf 6
Fuzhou 6
Jakarta 6
Shenzhen 6
Turin 6
Dalian 5
Johannesburg 5
Nanchang 5
Phoenix 5
San Francisco 5
Addis Ababa 4
Amman 4
Ankara 4
Ardabil 4
Bari 4
Brescia 4
Charleston 4
Honolulu 4
Hải Dương 4
Jinan 4
Lahore 4
Mexico City 4
Paris 4
Totale 4.827
Nome #
Economic burden of patients affected by non-small cell lung cancer (NSCLC): the LIFE study 163
Carcinoma sarcomatoide della prostata: caso clinico 153
Autophagy and thyroid carcinogenesis: genetic and epigenetic links 148
Resveratrol inhibits IL-6-induced ovarian cancer cell migration through epigenetic up-regulation of autophagy 146
PTEN deficiency and mutant p53 confer glucose-addiction to thyroid cancer cells: impact of glucose depletion on cell proliferation, cell survival, autophagy and cell migration. 141
Case report : Herceptin e carcinoma mammario 139
Integrins in T Cell Physiology 137
Activity and safety of RAD001 (everolimus) in patients affected by biliary tract cancer progressing after prior chemotherapy: a phase II ITMO study. 135
Aberrant somatic hypermutation in primary mediastinal large B-cell lymphoma 122
PTEN regulates plasma membrane expression of glucose transporter 1 and glucose uptake in thyroid cancer cells. 117
Adjuvant chemotherapy of pT1a and pT1b breast carcinoma: results from the NEMESI study 117
First-Line Bevacizumab-Based Therapy in Advanced Non-Squamous Non-Small-Cell Lung Cancer: Analysis of the Italian Patients Enrolled in the SAiL Study 116
Circannual variation of efficacy outcomes in patients with newly diagnosedmetastatic colorectal cancer and treated with first-line chemotherapy 116
Analysis of immunoglobulin heavy and light chain variable genes in post-transplant lymfoproliferative disorders 116
Comparison of the Tolerability Profile of Controlled-Release Oral Morphine and Oxycodone for Cancer Pain Treatment. An Open-Label Randomized Controlled Trial 115
Case report : Metastatic melanoma 113
Ependimoma anaplastico della regione dorso lombare in adulto: caso clinico 110
Safety and activity of docetaxel and trastuzumab in HER2 overexpressing metastatic breast cancer. a pilot phase II study 109
CARCINOMA DEL COLON METASTATICO: CASE REPORT 109
Mutation analysis of KRAS in primary colorectal cancer and matched metastases by means of highly sensitivity molecular assay. 109
Combined regional and systemic chemotherapy by a mini-invasive approach for the treatment of colorectal liver metastases 108
Association between ultrarapid CYP2D6 polymorphisms and adverse drug reactions among women with breast cancer treated with tamoxifen 107
Preliminary safety and efficacy of first-line pertuzumab combined with trastuzumab and taxane therapy for HER2-positive locally recurrent or metastatic breast cancer (PERUSE). 106
Mutation analysis of the EGFR gene and downstream signalling pathway in histologic samples of malignant pleural mesothelioma. 104
Migrazione epatica di cellule A-LAK autologhe espanse e marcate con 111Indio ex-vivo in pazienti affetti da metastasi epatiche di carcinoma del grosso intestino 103
Venous thromboembolism in lung cancer: retrospective analysis of data in outpatients treated at oncology department of Novara 103
Localizzazione gengivale metastatica in paziente affetta da carcinoma colorettale avanzato: caso clinico 102
Limits of aortic stop flow infusion chemotherapy in the treatment of advanced cancer 101
Docetaxel and Oxaliplatin in weekly administration in solid tumors: dose finding study 101
The role of lung metastasis resection in improving outcome of colorectal cancer patients: results from a large retrospective study 99
Risposta completa prolungata e terapia con sunitinib in paziente affetto da carcinoma a cellule renali metastatico 99
Disparity in the 'time to patient access' to new anti-cancer drugs in Italian regions. Results of a survey conducted by the Italian Society of Medical Oncology (AIOM) 98
Autophagy inhibition enhances anthocyanin-induced apoptosis in hepatocellular carcinoma 98
Neoplasia a primitività ignota: case report 97
FULD Combination Given as Hepatic Artery Infusion (HAI) in Colon-Rectal Liver Metastases (CLM) by a Percutaneously Placed Port-a-Cath (PAC) in Elderly or Unfit Patients (EUP) 96
Experience of integration among different lists in oncological equipe : doctors, nurses , psychologists 96
Carcinoma del colon metastatico: caso clinico. Bevacizumab e Capecitabina nella pratica clinica. Current therapeutics. Adis Milano 2006 96
The incidence of venous thromboembolism (VTE) in metastatic colorectal cancer (mCRC) patients 96
FISH in triple-negative breast cancer: a possible strategy for the future? 96
A phase II study of three-weekly docetaxel and weekly trastuzumab in HER2-overexpressing advanced breast cancer (ABC) 95
RMN DWIBS (Diffusion Weighet Body Imaging With Background Body Signal Suppression) WHOLE BODY in oncologia: studio osservazionale risultati preliminary 94
Tumore misto mülleriano dell’endometrio: case report 94
Venous thromboembolism in non-small cell lung cancer patients: retrospective analysis of cases treated at the Oncology Day Hospital of Novara, Italy 94
Expression and Clinical Significance of the Autophagy Proteins BECLIN 1 and LC3 in Ovarian Cancer 94
Preliminary Results of a Phase II Study with Gemcitabine and Continuous Infusion 5FU in Patients with Advanced or Metastatic Pancreatic Cancer 93
Singola localizzazione paravertebrale in seminoma testicolare: un caso clinico 93
Gemcitabine in vitro activity on hepatocellular carcinoma: basic pharmacological parameters and drug combinations 93
Continuous 5-fluorouracil infusion plus long acting octreotide in advanced well-differentiated neuroendocrine carcinomas. A phase II trial of the Piemonte oncology network 93
TCFW:5FUpvi in combination with weekly docetaxel and CDDP in advanced gastric cancer, a phase I-II study: the dose finding step."Rete Oncologica Piemontese" 90
Differences in the availability of new anti-cancer drugs for Italian patients treated in different regions. Results of analysis conducted by the Italian Society Of Medical Oncology 90
Final report of a phase II trial of Gemcitabine (GEM) with 5FU continous infusion (CI) in the treatment of advanced pancreatic cancer (APC) 88
Medical treatment choices for patients affected by advanced NSCLC in routine clinical practice: Results from the Italian observational "SUN" (Survey on the lUng cancer maNagement) study. Lung Cancer 88
Hepatic arterial infusion chemotherapy for Production and pro-apoptotic activity of soluble CD95 ligand in pancreatic carcinoma 86
High serum levels of Transforming Growth Factor-beta1, Interleukin-10 and Vascular Endothelial Growth Factor in pancreatic adenocarcinoma patients 85
Observational study on quality of life, safety, and effectiveness of first-line cetuximab plus chemotherapy in KRAS wild-type metastatic colorectal cancer patients: the ObservEr Study 85
Production and pro-apoptotic activity of soluble CD95 ligand in pancreatic carcinoma 84
Phase I trial of tomudex ( TOM ) + protracted – venous- infusion 5-fluorouracil (PVI-5FU ) in advanced ileal and colorectal cancer 83
Docetaxel plus androgen deprivation withdrawal may restore sensitivity to luteinizing hormone-releasing hormone analog therapy in castration-resistant prostate cancer patients 83
p27Kip1 is inactivated in human colorectal cancer by cytoplasmic localization associated with activation of Akt/PKB 82
Impact of use of oral anticancer drugs on activity of Italian oncology practices: results of a survey conducted by the Italian Society of Medical Oncology (AIOM) 82
Pelvic Intra-Arterial Infusion via Percutaneous Arterial Port for Locoregional Chemotherapy of Cancer Relapses 82
Port in oncology practice: 3-monthly locking with normal saline for catheter maintenance, a preliminary report 82
Phase II study of pemetrexed in combination with carboplatin in patients with malignant pleural mesothelioma (MPM) 81
Tolerability and compliance to chemotherapy in psychiatric patients with cancer 78
Tossicita’ da trattamento con Bevacizumab: l’esperienza della S.C.D.U. Oncologia medica di Novara 77
Inguinal sentinel node in anal neoplasms 76
Whole-body diffusion-weighted magnetic resonance imaging in the staging of oncological patients: comparison with positron emission tomography computed tomography (PET-CT) in a pilot study 75
Seminoma del testicolo: localizzazione paravertebrale di malattia: caso clinico 74
Side effects associated with ultrarapid cytochrome P450 2D6 genotype among women with early stage breast cancer treated with tamoxifen 73
Efficacy and Safety of RAD001 as Second Line Therapy in Biliary Tract Cancer (BTC) Patients (pts) – a Phase II I.T.M.O. (Italian Trials in Medical Oncology) Group Study 73
Palliative treatment for elderly patients with colon cancer in ten Italian medical oncology units 72
Interim Results of a Phase II Trial of Raltitrexed (RAL) + Protracted-Venous-Infusion-5-Fluorouracil (PVI-5-FU) in Advanced Colorectal Cancer 71
The CAP-CR study: direct medical costs in Italian metastatic colorectal cancer patients on first-line infusional 5-fluorouracil or oral capecitabine 71
Feasibility of fludarabine based treatment for lymphoproliferative disorders in patients over eighty years old 70
Tolerability and compliance to chemotherapy in neuropsychiatric patients 70
Involvement of autophagy in ovarian cancer: a working hypothesis 67
Intra-arterial continuous infusion for treatment of pancreatic and biliary tract cancer 67
Increased detection sensitivity for KRAS mutations enhances the prediction of anti-EGFR monoclonal antibody resistance in metastatic colorectal cancer 67
Stage IV gastric cancer and FOLFOX 6. Case report 65
Safety and activity of docetaxel and trastuzumab in HER2 overexpressing metastatic breast cancer: a pilot phase II study 64
Topotecan (T) and ifosfamide (I) as salvage treatment in advanced ovarian cancer 64
Prognostic significance of changes in CA 15-3 serum levels during chemotherapy in metastatic breast cancer patients 64
Riflessione sugli aspetti psicosociali in oncologia 64
The role of haemoglobin level in predicting the response to first-line chemotherapy in advanced colorectal cancer patients 64
Preliminary results of phase II trial with combination of gemcitabine and oxaliplatin in elderly patients with advanced NSCLC 63
Impact of hemoglobin levels in psychiatric patients with cancer 63
Prophylactic effect of reduced glutathione (GSH) on oxaliplatin chronic cumulative neurotoxicity (CCN) 62
Two cases of secondary soft tissue sarcomas after radiotherapy and radiochemiotherapy 60
Pericardial metastases in a long-surviving patient with sigmoid carcinoma 59
Prospective study on prognostic significance of DNA ploidy and Ki-67 expression in colorectal cancer 59
Secondary neoplasms: our experience 57
Variation in gynecological oncology follow-up practice: attributable to cancer centers or to patient characteristics? A Piedmont Regional Oncology Network Study 56
The role of hemoglobin level in predicting the response to first-line chemotherapy in advanced colorectal cancer (ACC) patients 52
null 34
Totale 8.582
Categoria #
all - tutte 41.552
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 41.552


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202121 0 0 0 0 0 0 0 0 0 0 0 21
2021/2022676 26 8 138 57 35 1 91 13 40 17 134 116
2022/20231.360 107 37 62 36 115 123 37 73 711 3 36 20
2023/2024365 27 19 40 4 81 2 88 4 4 10 28 58
2024/2025938 23 28 50 12 30 123 120 47 260 78 32 135
2025/20263.005 128 82 205 296 303 254 480 544 242 298 139 34
Totale 8.582